QuidelOrtho (QDEL) Cost of Revenue (2021 - 2024)

QuidelOrtho has disclosed Cost of Revenue across 4 years of filings, most recently posting $8.0 million for Q1 2024.

• Cost of Revenue for Q1 2024 came in at $8.0 million, down 97.99% year-over-year; the trailing twelve-month figure through Mar 2024 was -$501.3 million (down 128.93% YoY), and the FY2024 annual result was $1.5 billion, up 5421.77% from the prior year.
• Cost of Revenue came in at $8.0 million for Q1 2024 at QuidelOrtho, up from -$885.4 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $1.1 billion in Q1 2023 to a low of -$885.4 million in Q4 2023.
• The 4-year median for Cost of Revenue is $68.6 million (2021), against an average of $144.4 million.
• Across the five-year window, Cost of Revenue surged 302.19% in 2022 and tumbled 183.91% in 2023, its largest moves.
• QuidelOrtho's Cost of Revenue stood at $68.6 million in 2021, then sank by 94.17% to $4.0 million in 2022, then slumped by 22235.0% to -$885.4 million in 2023, then surged by 100.9% to $8.0 million in 2024.
• The last three Cost of Revenue figures came in at $8.0 million (Q1 2024), -$885.4 million (Q4 2023), and $7.4 million (Q4 2023), per Business Quant data.